Drugmaker Janux Therapeutics Inc. is exploring options, including a potential sale, after receiving takeover interest from larger pharmaceutical companies, people with knowledge of the matter said. The company, which develops tumor-activated immunotherapies to treat cancer, is working with a financial adviser to evaluate possibilities including a sale, according to the people, who asked not to be identified discussing confidential information.
Read the full article: Cancer-Drug Maker Janux Therapeutics Weighs Possible Sale //
Source: https://www.bloomberg.com/news/articles/2024-04-10/cancer-drug-maker-janux-therapeutics-said-to-weigh-possible-sale